# Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)

> **NCT00909298** · PHASE2 · TERMINATED · sponsor: **vTv Therapeutics** · enrollment: 2 (actual)

## Conditions studied

- Coagulation

## Interventions

- **DRUG:** TTP889
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00909298
- **Lead sponsor:** vTv Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** —
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2011-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909298, "Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00909298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*